Rare diseases
Investigational molecules
Locations
Back to Spain371 clinical trials in Palma, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainStudy on the Safety of ELGN-2112 for Preterm Infants with Intestinal Malabsorption
SpainComparison of Short vs Long-term Hormone Therapy with Goserelin, Leuprorelin, or Triptorelin Combined with Radiation for Prostate Cancer Patients After Surgery
SpainStudy on Olaparib and Bevacizumab for Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Cancer
SpainStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination
SpainStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
SpainStudy on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment
SpainStudy on the Effects of Continuing or Stopping Simvastatin and Atorvastatin in Patients with Spontaneous Lobar Intracerebral Hemorrhage
SpainStudy on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response
SpainStudy on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase
SpainSpainStudy of Tulmimetostat (CPI-0209) for Patients with Advanced Solid Tumors and Lymphomas
SpainThe busiest research cities in the country
What the registry says about research in the country
The cancer research activity in Palma De Mallorca focuses on improving treatment options for multiple myeloma, relapsed refractory multiple myeloma, acute myeloid leukemia, myelodysplastic syndrome, and advanced non-small cell lung cancer. These studies are designed to assess whether newer therapies can improve disease control and patient outcomes.
Across these trials, researchers are comparing innovative approaches with existing care to better understand how to extend survival and deepen responses.
Clinical trial work in cardiovascular diseases is centered on primary prevention of atherosclerotic cardiovascular disease. The main goal is to see whether new preventive strategies can lower the risk of serious heart and vascular events in people at elevated risk.
These studies aim to strengthen early prevention and support better long-term cardiovascular health.
This research area includes studies in hematologic cancers such as multiple myeloma, relapsed refractory multiple myeloma, acute myeloid leukemia, and myelodysplastic syndrome. The focus is on testing therapies that may improve control of blood-related malignancies and deepen treatment responses.
Investigators are working to refine treatment strategies for patients with difficult-to-treat hematologic conditions.
Trials in nervous system diseases are exploring better ways to prevent and ease chronic postsurgical pain after inguinal hernia repair. The aim is to reduce the chance that short-term surgical pain becomes a lasting problem.
These studies focus on making recovery more comfortable and helping patients return to normal activity more smoothly.
Research in stomatognathic diseases is examining ways to prevent clinically relevant oral bleeding after tooth extraction in patients using direct oral anticoagulants or vitamin K antagonists. The purpose is to improve safety in everyday dental care for people on blood-thinning treatment.
These studies aim to support safer dental procedures without compromising cardiovascular protection.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
